Comparative economic evaluation of quetiapine plus lamotrigine combination vs quetiapine monotherapy(and folic acid vs placebo) in patients with bipolar depression (CEQUEL)

Economic evaluations in the field of psychiatry are still scarce. The article by Simon et al (2018) is unique as it proposes a comparative economic analysis of the association between lamotrigine and quetiapine (first-line treatment) in acute bipolar depression . Different economic analyses have alr...

Full description

Saved in:
Bibliographic Details
Published in:Bipolar disorders 2019-03, Vol.21 (2), p.172-173
Main Authors: Silva Lima, Ana Flávia Barros da, Cohen, Mirian, Miguel, Sandro, Cruz, Luciane
Format: Article
Language:English
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c2857-c92295dbe5759ec8edafe45b52b8ebe85062b86b1b97a7d071cfd36a1235fe7c3
container_end_page 173
container_issue 2
container_start_page 172
container_title Bipolar disorders
container_volume 21
creator Silva Lima, Ana Flávia Barros da
Cohen, Mirian
Miguel, Sandro
Cruz, Luciane
description Economic evaluations in the field of psychiatry are still scarce. The article by Simon et al (2018) is unique as it proposes a comparative economic analysis of the association between lamotrigine and quetiapine (first-line treatment) in acute bipolar depression . Different economic analyses have already been performed with lamotrigine for disorders such as epilepsy, borderline personality disorder, and Lennox-Gastaut Syndrome. This article is protected by copyright. All rights reserved.
doi_str_mv 10.1111/bdi.12747
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2179548787</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2179548787</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2857-c92295dbe5759ec8edafe45b52b8ebe85062b86b1b97a7d071cfd36a1235fe7c3</originalsourceid><addsrcrecordid>eNp1kctq3DAUhkVpaC7tIi9QtJxZTGLJI0teppPJBQZCoVkbXY4TFdlSJHvCvFMfspo4CdnkbPRz-M4H4kfolBRnJM-5MvaMUL7kX9ARKet6wSoivr5kkfOSH6LjlP4WBalowb6hw7KoalHS6gj9W_kuyCgHuwUM2ve-sxrDVrox73yPfYufRhisDLYHHNyYsJOdH6J92C-075TtJ3SbPqJddg2PEGXYzWRvcOtdNkttzR4MTmpQfo5tj0M-h35I-NkOj1jZ4J2M2ECIkNJePFutf9-vN_Pv6KCVLsGP1_cE3V-t_6xuFpu769vVxWahqWB8oWtKa2YUMM5q0AKMbGHJFKNKgALBiiqnShFVc8lNwYluTVlJQkvWAtflCZpN3hB9_lEams4mDc7JHvyYGkp4zZaCC57R-YTq6FOK0DYh2k7GXUOKZl9Ok8tpXsrJ7M9X7ag6MO_kWxsZOJ-AZ-tg97mp-XV5Oyn_A5ZrnWY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2179548787</pqid></control><display><type>article</type><title>Comparative economic evaluation of quetiapine plus lamotrigine combination vs quetiapine monotherapy(and folic acid vs placebo) in patients with bipolar depression (CEQUEL)</title><source>Wiley:Jisc Collections:Wiley Read and Publish Open Access 2024-2025 (reading list)</source><creator>Silva Lima, Ana Flávia Barros da ; Cohen, Mirian ; Miguel, Sandro ; Cruz, Luciane</creator><creatorcontrib>Silva Lima, Ana Flávia Barros da ; Cohen, Mirian ; Miguel, Sandro ; Cruz, Luciane</creatorcontrib><description>Economic evaluations in the field of psychiatry are still scarce. The article by Simon et al (2018) is unique as it proposes a comparative economic analysis of the association between lamotrigine and quetiapine (first-line treatment) in acute bipolar depression . Different economic analyses have already been performed with lamotrigine for disorders such as epilepsy, borderline personality disorder, and Lennox-Gastaut Syndrome. This article is protected by copyright. All rights reserved.</description><identifier>ISSN: 1398-5647</identifier><identifier>EISSN: 1399-5618</identifier><identifier>DOI: 10.1111/bdi.12747</identifier><identifier>PMID: 30698326</identifier><language>eng</language><publisher>Denmark</publisher><ispartof>Bipolar disorders, 2019-03, Vol.21 (2), p.172-173</ispartof><rights>2019 John Wiley &amp; Sons A/S. Published by John Wiley &amp; Sons Ltd</rights><rights>This article is protected by copyright. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c2857-c92295dbe5759ec8edafe45b52b8ebe85062b86b1b97a7d071cfd36a1235fe7c3</cites><orcidid>0000-0001-6792-9971</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27922,27923</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30698326$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Silva Lima, Ana Flávia Barros da</creatorcontrib><creatorcontrib>Cohen, Mirian</creatorcontrib><creatorcontrib>Miguel, Sandro</creatorcontrib><creatorcontrib>Cruz, Luciane</creatorcontrib><title>Comparative economic evaluation of quetiapine plus lamotrigine combination vs quetiapine monotherapy(and folic acid vs placebo) in patients with bipolar depression (CEQUEL)</title><title>Bipolar disorders</title><addtitle>Bipolar Disord</addtitle><description>Economic evaluations in the field of psychiatry are still scarce. The article by Simon et al (2018) is unique as it proposes a comparative economic analysis of the association between lamotrigine and quetiapine (first-line treatment) in acute bipolar depression . Different economic analyses have already been performed with lamotrigine for disorders such as epilepsy, borderline personality disorder, and Lennox-Gastaut Syndrome. This article is protected by copyright. All rights reserved.</description><issn>1398-5647</issn><issn>1399-5618</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNp1kctq3DAUhkVpaC7tIi9QtJxZTGLJI0teppPJBQZCoVkbXY4TFdlSJHvCvFMfspo4CdnkbPRz-M4H4kfolBRnJM-5MvaMUL7kX9ARKet6wSoivr5kkfOSH6LjlP4WBalowb6hw7KoalHS6gj9W_kuyCgHuwUM2ve-sxrDVrox73yPfYufRhisDLYHHNyYsJOdH6J92C-075TtJ3SbPqJddg2PEGXYzWRvcOtdNkttzR4MTmpQfo5tj0M-h35I-NkOj1jZ4J2M2ECIkNJePFutf9-vN_Pv6KCVLsGP1_cE3V-t_6xuFpu769vVxWahqWB8oWtKa2YUMM5q0AKMbGHJFKNKgALBiiqnShFVc8lNwYluTVlJQkvWAtflCZpN3hB9_lEams4mDc7JHvyYGkp4zZaCC57R-YTq6FOK0DYh2k7GXUOKZl9Ok8tpXsrJ7M9X7ag6MO_kWxsZOJ-AZ-tg97mp-XV5Oyn_A5ZrnWY</recordid><startdate>201903</startdate><enddate>201903</enddate><creator>Silva Lima, Ana Flávia Barros da</creator><creator>Cohen, Mirian</creator><creator>Miguel, Sandro</creator><creator>Cruz, Luciane</creator><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-6792-9971</orcidid></search><sort><creationdate>201903</creationdate><title>Comparative economic evaluation of quetiapine plus lamotrigine combination vs quetiapine monotherapy(and folic acid vs placebo) in patients with bipolar depression (CEQUEL)</title><author>Silva Lima, Ana Flávia Barros da ; Cohen, Mirian ; Miguel, Sandro ; Cruz, Luciane</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2857-c92295dbe5759ec8edafe45b52b8ebe85062b86b1b97a7d071cfd36a1235fe7c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Silva Lima, Ana Flávia Barros da</creatorcontrib><creatorcontrib>Cohen, Mirian</creatorcontrib><creatorcontrib>Miguel, Sandro</creatorcontrib><creatorcontrib>Cruz, Luciane</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Bipolar disorders</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Silva Lima, Ana Flávia Barros da</au><au>Cohen, Mirian</au><au>Miguel, Sandro</au><au>Cruz, Luciane</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Comparative economic evaluation of quetiapine plus lamotrigine combination vs quetiapine monotherapy(and folic acid vs placebo) in patients with bipolar depression (CEQUEL)</atitle><jtitle>Bipolar disorders</jtitle><addtitle>Bipolar Disord</addtitle><date>2019-03</date><risdate>2019</risdate><volume>21</volume><issue>2</issue><spage>172</spage><epage>173</epage><pages>172-173</pages><issn>1398-5647</issn><eissn>1399-5618</eissn><abstract>Economic evaluations in the field of psychiatry are still scarce. The article by Simon et al (2018) is unique as it proposes a comparative economic analysis of the association between lamotrigine and quetiapine (first-line treatment) in acute bipolar depression . Different economic analyses have already been performed with lamotrigine for disorders such as epilepsy, borderline personality disorder, and Lennox-Gastaut Syndrome. This article is protected by copyright. All rights reserved.</abstract><cop>Denmark</cop><pmid>30698326</pmid><doi>10.1111/bdi.12747</doi><tpages>2</tpages><orcidid>https://orcid.org/0000-0001-6792-9971</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1398-5647
ispartof Bipolar disorders, 2019-03, Vol.21 (2), p.172-173
issn 1398-5647
1399-5618
language eng
recordid cdi_proquest_miscellaneous_2179548787
source Wiley:Jisc Collections:Wiley Read and Publish Open Access 2024-2025 (reading list)
title Comparative economic evaluation of quetiapine plus lamotrigine combination vs quetiapine monotherapy(and folic acid vs placebo) in patients with bipolar depression (CEQUEL)
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T10%3A45%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Comparative%20economic%20evaluation%20of%20quetiapine%20plus%20lamotrigine%20combination%20vs%20quetiapine%20monotherapy(and%20folic%20acid%20vs%20placebo)%20in%20patients%20with%20bipolar%20depression%20(CEQUEL)&rft.jtitle=Bipolar%20disorders&rft.au=Silva%20Lima,%20Ana%20Fl%C3%A1via%20Barros%20da&rft.date=2019-03&rft.volume=21&rft.issue=2&rft.spage=172&rft.epage=173&rft.pages=172-173&rft.issn=1398-5647&rft.eissn=1399-5618&rft_id=info:doi/10.1111/bdi.12747&rft_dat=%3Cproquest_cross%3E2179548787%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c2857-c92295dbe5759ec8edafe45b52b8ebe85062b86b1b97a7d071cfd36a1235fe7c3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2179548787&rft_id=info:pmid/30698326&rfr_iscdi=true